TPM3 and metabolic dysfunction-associated steatotic liver disease: To compare effects on NAFLD between the wild type and htM5, HFD-fed mice were intraperitoneally injected with 0.1 or 0.5 mg/kg of htFGF21 or htM5, once daily for 14 days.